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What are Medically Unexplained Symptoms? 
 
Bodily symptoms are common in community samples, but not all people consult for medical 
advice about such symptoms. Medically Unexplained Symptoms (MUS) refers to persistent 
bodily complaints for which adequate examination (including investigation) does not reveal 
sufficiently explanatory structural or other specified pathology (1).  MUS are common, with a 
spectrum of severity, and patients are found everywhere within the health care system (2). It 
has been estimated that MUS account for up to 45% of all general practice (GP) 
consultations (3), whilst a study based in secondary care indicated that about 50% of 
patients had no clear diagnosis at 3 months (2).  
 
 
What are the costs of MUS? 
 
The annual NHS cost for MUS in adults of working age in England was estimated to be 
£2.89bn in 2008/9 (11% of total NHS spend), whilst sickness absence and decreased quality 
of life for people with MUS was estimated as costing over £14 billion per annum to the UK 
economy (4).  
 
Whilst the costs to the NHS and the economy are important considerations, the personal 
cost to the patient can also be significant. People often experience stress, distress and 
anxiety because of their unexplained symptoms. They report feeling that their concerns are 
not taken seriously by their doctor, which can exacerbate the presentation of somatic 
symptoms. The suggestion that ‘negative test results means that nothing is wrong’, is cited 
as the most common explanation given by doctors (5), but patients can feel that their 
symptoms are not believed, and may disengage from healthcare (including for other co-
morbid problems). The anxiety associated with symptoms which have not been adequately 
explained can lead to repeated presentations to their GP and/or the Emergency Department 
(ED) as well as potentially inappropriate referrals for investigations and specialist opinions, 
or the seeking of alternative therapies – which are costly for both the patient and the health 
service (6). The pursuit of inappropriate investigations in an effort to find the cause of 
patients’ symptoms or avoid litigation can cause significant harm to the patient. Such 
procedures can exacerbate anxiety, lead to further investigation of incidental findings and 
the potential for over-treatment and un-necessary interventions, including medication which 
can lead to side-effects and addiction. 
 
The origins of, and need for, emotional support in coping with MUS are often overlooked by 
doctors, who may focus solely on physical symptoms or use less patient-centred 
approaches with people with MUS (7), although research indicates that such patients may 
want to discuss their emotional well-being more than patients presenting with symptoms with 
a clear-cut organic basis (8).  
 
Managing people with MUS also impacts on clinicians, due to the inherent difficulties in 
establishing a ‘diagnosis’ (particularly where a medical model is being employed). Thus, 
General Practitioners (GPs) report less satisfaction when caring for patients with persistent 
MUS than for patients with psychological problems. Wileman et al (9) reported how some 
GPs described a sense of powerlessness during the course of a consultation, and how the 
negative emotions experienced by doctors can have a major impact on the doctor-patient 
relationship, resulting in emotions which may impact on their professional judgement. Many 
GPs reported a sense of inadequacy and insecurity due to an inability to treat the presenting 
complaints, and some described quite striking feelings of resentment towards the patient, 
together with a sense of a lack of control within the consultation (9): 
 
‘Some make your stomach churn when they come in…very nervous. They make it very clear 
they are taking charge; and they do, they take charge, and there is nothing you can do.’ (GP 
quoted in Wileman paper). 
 
Some of this frustration is attributed to the diagnostic uncertainty which can add to clinicians’ 
professional uncertainty. GPs may fear missing serious pathology, which may lead to 
referral for repeated, un-necessary investigations. There is limited evidence about the 
attitudes of secondary care clinicians to working with patients with MUS, but a recent study 
reports how poorly prepared junior doctors felt in assessing and caring for such patients, 
with doctors reporting feelings of anxiety, frustration and a self-perceived lack of 
competency, admitting to over-investigating patients, or avoiding patient contact altogether 
due to the challenging nature of MUS (10). 
 
How should people with MUS be managed? 
As most people with MUS will present to primary care, GPs need to ensure they feel 
comfortable in  identifying  and recognising that the presented symptoms may be 
unexplainable, feel suitably skilled in  sharing this with the patient, and give initial advice. 
Guidance produced by the RCGP and RCPsych emphasises the role of the GP in helping 
the patient make sense of their symptoms (11). The guidance suggests that the GP should 
always take the patient’s concerns seriously and fully explore them, being aware of cues 
which may indicate distress; the GP should focus on the impact of symptoms, rather than 
searching for a diagnosis. The GP needs to discuss the likelihood of planned blood tests and 
other investigations being normal, to prevent the patient being disappointed that ‘nothing has 
been found’. In addition, the GP needs to share their uncertainty with the patient, as well as 
sharing decisions about further investigation and management. 
 
The approach may include the use of explanatory models or metaphors (12,13,14), 
addressing the patient’s fears and building on the patient’s strengths. The use of time, and 
continuity of care, is emphasised. In addition, the need for the GP to be able to manage their 
own anxiety and uncertainty is emphasised.  
 
If symptoms are addressed satisfactorily, people may not go on to develop multiple 
symptoms or become frequent attenders. There are evidence-based ways to manage 
people with MUS in primary care (15), and currently, in England, the IAPT [Improving 
Access to Psychological Therapies, (16)] teams are tasked with managing people with mild-
to-moderate MUS. However, IAPT services can be perceived by patients to offer services for 
mental health problems and may not be acceptable to some patients;  in addition IAPT does 
not meet the needs of patients with more complex problems.  
 
 
How should services for people with MUS be configured? 
Whilst many people with MUS can be sensitively and effectively managed in primary care, 
some people with more complex problems will require access to more specialist services. 
The commissioning guidance on MUS[cc1] (link) suggests that such services should be 
person-centred, accessible, and needs-based, enabling patients to recover as fully as 
possible. The emphasis should be on early intervention, and services which are accessible 
and acceptable to patients. The commissioning guidance emphasises the need for care 
pathways which integrate physical and mental healthcare and join primary, secondary and 
tertiary services seamlessly. This may involve a stepped care model, with the intensity of the 
intervention being proportional to the complexity of the patient’s problem. What is vital is 
information-sharing between clinicians which will support properly integrated holistic care for 
MUS based on systems which will enable close liaison between GPs, ED and acute 
specialists. All clinicians should be able to assess patient’s problems, taking a positive 
approach to symptom management and ensuring collaborative working. There is in addition 
a role for specialist clinicians who have additional competencies and capacity to support the 
management of people with complex problems, delivering training and liaising with more 
generalist clinicians. 
 
In summary, to meet the challenges of managing people with MUS, a multidisciplinary 
approach is required which brings together a broad range of clinicians (from general 
practice, medicine, nursing, psychology/psychotherapy, psychiatry, occupational therapy 
and physiotherapy) and which integrates physical and mental healthcare services. 
Innovative approaches, including the use of metaphors to explain MUS (13, 14) and to aid 
clinicians in the support and management of people with MUS, are needed.  
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